文献速递性腺与生殖内分泌

体重指数升高与抗苗勒管激素的非稀释性降低相关

Increased Body Mass Index Is Associated With A Nondilutional Reduction in Antimüllerian Hormone.
PubMed 文献 · J Clin Endocrinol Metab · 2020-01-01

多中心队列纳入640例多囊卵巢综合征(PCOS)女性和921例排卵正常对照(OVA),年龄25至40岁。校正年龄、种族、吸烟和中心后,BMI和腰围升高与AMH及AMH/抗窦卵泡计数(AFC)比值降低相关;控制体表面积(BSA)后BMI仍与AMH独立相关,而BSA不再与AMH相关。作者认为数据不支持血液稀释介导体形增大与AMH降低的关系,卵泡单位AMH生成减少可能起作用。

要点

  • PCOS与OVA两队列中,BMI和腰围升高均与AMH及AMH/AFC降低相关。
  • 控制BSA后BMI仍与AMH独立相关,BSA不再与AMH相关,不支持稀释效应。
  • BMI升高与AFC降低仅在PCOS中相关,在OVA中不相关。

核心结论

  • 校正分析中,与AMH降低相关的是BMI而非BSA,数据不支持血液稀释介导体形增大与AMH降低的关系。
  • 卵泡单位AMH生成减少可能是BMI升高时AMH降低的原因。

研究设计与样本

  • 多中心队列研究,纳入2个临床人群的25至40岁女性:640例PCOS患者和921例排卵正常对照(OVA)。
  • 多变量回归模型校正年龄、种族、吸烟和中心。

主要发现

  • 两队列中,BMI和腰围升高均与AMH及AMH/AFC降低相关。
  • BMI升高与AFC降低在PCOS中相关,在OVA中不相关。
  • 控制BSA后,BMI在两队列中仍与AMH独立相关,BSA不再与AMH相关。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: Controversy exists regarding if and how body mass index (BMI) impacts antimüllerian hormone (AMH) in women with and without polycystic ovary syndrome (PCOS). Understanding the BMI-AMH relationship has critical implications for clinical interpretation of laboratory values and could illuminate underlying ovarian physiology. OBJECTIVE: To test the hypotheses that (1) BMI is associated with reduced AMH in PCOS and ovulatory controls (OVAs) and (2) the reduction in AMH is not accounted for by dilutional effects. DESIGN/SETTING: Multicenter cohort. PARTICIPANTS: Women aged 25 to 40 years from 2 clinical populations: 640 with PCOS, 921 women as OVAs. MAIN OUTCOME MEASURES: Ovarian reserve indices: AMH, antral follicle count (AFC), and AMH to AFC ratio (AMH/AFC) as a marker of per-follicle AMH production. RESULTS: In both cohorts, increasing BMI and waist circumference were associated with reductions in AMH and AMH/AFC, after adjusting for age, race, smoking, and site in multivariate regression models. Increasing BMI was associated with reduced AFC in PCOS but not OVAs. Body surface area (BSA), which unlike BMI is strongly proportional to plasma volume, was added to investigate a potential dilutive effect of body size on AMH concentrations. After controlling for BSA, BMI retained independent associations with AMH in both cohorts; BSA no longer associated with AMH. CONCLUSIONS: In an adjusted analysis, BMI, but not BSA, was associated with reduced AMH; these data do not support a role for hemodilution in mediating the relationship between increased body size and reduced AMH. Decreased AMH production by the follicle unit may be responsible for reduced AMH with increasing BMI.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Jaswa EG, Rios JS, Cedars MI, et al. Increased Body Mass Index Is Associated With A Nondilutional Reduction in Antimüllerian Hormone. J Clin Endocrinol Metab. 2020. PMID: 32756952. doi:10.1210/clinem/dgaa436

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。